Imperial Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.27 M
as on 11-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.11 Cr
as on 11-12-2024
- Revenue 41.60%
(FY 2023)
- Profit 71.23%
(FY 2023)
- Ebitda 10.34%
(FY 2023)
- Net Worth 260.25%
(FY 2023)
- Total Assets 22.49%
(FY 2023)
About Imperial Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.27 M.
The company currently has active open charges totaling ₹2.11 Cr.
Darshitam Goyal and Swati Goyal serve as directors at the Company.
- CIN/LLPIN
U51397DL2020PTC365353
- Company No.
365353
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Imperial Biotech Private Limited offer?
Imperial Biotech Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Pathology Lab Equipments, Blood Bank Equipments, Autoclaves, Sterilizers & Incubators, Lab Incubator, Hospital and Medical Furniture, Hospital Furniture, Hospital Bed and Mattress, Medical Trolley, Wash Basins, Sanitaryware & Fittings.
Who are the key members and board of directors at Imperial Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darshitam Goyal  | Director | 29-Jun-2020 | Current |
| Swati Goyal | Additional Director | 03-Sep-2024 | Current |
Financial Performance of Imperial Biotech.
Imperial Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.6% increase. The company also saw a substantial improvement in profitability, with a 71.23% increase in profit. The company's net worth Soared by an impressive increase of 260.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imperial Biotech?
Unlock access to Imperial Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 09 Sep 2022 | ₹2.10 M | Open |
Indian Overseas Bank Creation Date: 26 Feb 2021 | ₹1.90 Cr | Open |
How Many Employees Work at Imperial Biotech?
Imperial Biotech has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imperial Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imperial Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
